DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 3.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 44.7. According to RSI analysis, drreddy is weak. 3.0 DRREDDY RSI Chart
MACD (?) MACD: 0.492 and Signal Line: -8.22. According to MACD analysis, drreddy is technically strong. 8.0 DRREDDY MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2624.628, 2653.172, 2971.928. 1.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2640.803, 2686.613, 2923.616. 1.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.437. 5.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 2772.1791 and 2849.475. Support level is 2521.95. 2.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 55.1 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 18.8 which means DRREDDY is in a trading range and there is no trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
May 22, 2017
Open Price 2680.0
High Price 2681.95
Low Price 2602.1
Close Price 2608.7
Absolute Change -47.75
Percentage Change -1.8%
Weekly Change -2.51%
Monthly Change -0.0364%
Yearly Change -13.1%
52-week high 3689.85
52-week low 2521.95
Corporate Actions
ExDate Purpose
July 18, 2016 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.491
Confidence in Beta1.17%
Market Capital Rs. 44499.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 33
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 22 May 2017: Deliverable Quantity:6.91e+04 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 22 May 2017: Daily Volatility:0.2598 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 22 May 2017: PCR_OI:0.436 PCR:0.528 NA DRREDDY PCR Chart
Premium (?) 22 May 2017 Premium: 6.85 Futures OI:2433800.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 22 May 2017: Price:2608.7 Put with maximum OI:2500.0 Call with maximum OI:2800.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
May 25, 2017 2615.55 2433800.0 3271.0 3672.0 2608.7
June 29, 2017 2628.0 515000.0 1575.0 1901.0 2608.7
July 27, 2017 2625.05 91000.0 64.0 79.0 2608.7

Announcements

May 17, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 17, 2017, titled "Dr. Reddy's Laboratories announces USFDA approval for the launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market.".
May 15, 2017 Dr.ESOP/ESOS/ESPS. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 214516 Options. This is to inform you that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 11, 2017, has granted 151,212 stock options, exercisable at par value of Rs.5/- under Dr. Reddy s Employees Stock Option Scheme, 2002 and 63,304 stock options, exercisable at par value of Rs.5/- under Dr. Reddy s Employees ADR Stock Option Scheme, 2007 to the employees of the Company.
See all Announcements

Board Meetings

Date Meeting Date Purpose
April 18, 2017 May 12, 2017 intResults/Dividendter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2017 and recommend dividend, if any, for the financial year 2016-17. Further, that the Company s trading window for dealing in securities by the Insiders is closed from April 26, 2017 and ending on May 14, 2017 (both days inclusive).
January 10, 2017 February 04, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2500 Rs. 2551 Rs. 2580 Rs. 2631 Rs. 2660 Rs. 2711 Rs. 2740